BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...

BTIG analyst Gregory Lewis maintained a Buy rating on DHT Holdings (DHT – Research Report) yesterday and set a price target of $16.00. The ...

BTIG analyst Gray Powell raised the firm’s price target on CyberArk (CYBR) to $485 from $407 and keeps a Buy rating on the shares. The company ...

Apollo Commercial Real Estate Finance (NYSE:ARI), currently trading at $9.09 with a market capitalization of $1.26 billion, maintained a Neutral stock rating from BTIG following the company's ...

Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend BTIG’s MedTech, ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...

For more information about the conference, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

BTIG Research initiated coverage on shares of ARMOUR Residential REIT (NYSE:ARR – Free Report) in a report issued on Monday, MarketBeat reports. The brokerage issued a neutral rating on the real ...

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...